Related Experiment Video
Updated: Jun 4, 2025
12:03
Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors
Published on: July 8, 2012
18.6K
Reducing functionally defective old HSCs alleviates aging-related phenotypes in old recipient mice
Yuting Wang1,2,3, Wenhao Zhang1,2,3, Chao Zhang1,2,3
1Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA, USA.
Cell Research
|January 1, 2025
Summary
Transplanting young hematopoietic stem cells (HSCs) into old mice reverses aging signs. A specific subset of aged HSCs (CD150low) retains youthful function, offering a new anti-aging strategy.
Area of Science:
- Gerontology
- Hematology
- Stem Cell Biology
Background:
- Aging is characterized by progressive functional decline in tissues and organs.
- Effective anti-aging interventions are crucial for public health.
- Hematopoietic stem cells (HSCs) play a role in the aging process.
Purpose of the Study:
- To investigate the role of HSCs in aging.
- To identify specific HSC subsets with altered function in aged individuals.
- To explore therapeutic potential of manipulating HSCs for anti-aging strategies.
Main Methods:
- Transplantation of young and old hematopoietic stem cells (HSCs) into aged mice.
- Comprehensive molecular and functional analyses of HSC subsets.
- Assessment of aging phenotypes and lifespan following HSC transplantation.
Main Results:
- Young HSC transplantation mitigated aging phenotypes in old mice.
- A subset of aged HSCs (CD150low) exhibited younger molecular profiles and retained differentiation capacity.
- Transplantation of aged CD150low HSCs attenuated aging phenotypes and prolonged lifespan.
- Reducing dysfunctional CD150high HSCs alleviated aging phenotypes in aged mice.
Conclusions:
- Aged mice harbor a subset of "younger" HSCs (CD150low) with preserved function.
- Manipulation of HSC subsets, particularly reducing dysfunctional CD150high HSCs, can mitigate aging phenotypes.
- Targeting HSCs presents a promising strategy for combating age-related functional decline.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K